Obesity and diabetes in the developing world--a growing challenge.

PubWeight™: 10.54‹?› | Rank: Top 0.1%

🔗 View Article (PMID 17229948)

Published in N Engl J Med on January 18, 2007

Authors

Parvez Hossain1, Bisher Kawar, Meguid El Nahas

Author Affiliations

1: Academic Nephrology Unit at the Sheffield Kidney Institute, University of Sheffield, Sheffield, United Kingdom.

Associated clinical trials:

High-intensity Interval Training for Obese Individuals | NCT04075799

Articles citing this

(truncated to the top 100)

Identification and importance of brown adipose tissue in adult humans. N Engl J Med (2009) 20.57

Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell (2010) 10.96

Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen (2009) 7.29

The culture, community, and science of type 2 diabetes prevention in the US Associated Pacific Islands. Prev Chronic Dis (2009) 3.95

Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ (2009) 3.68

Discovery of common Asian copy number variants using integrated high-resolution array CGH and massively parallel DNA sequencing. Nat Genet (2010) 3.49

Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss. Diabetes (2008) 3.47

Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes Care (2013) 3.43

Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol (2010) 3.23

Retracted Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol (2011) 3.02

BET domain co-regulators in obesity, inflammation and cancer. Nat Rev Cancer (2012) 2.80

Effects of dairy intake on body weight and fat: a meta-analysis of randomized controlled trials. Am J Clin Nutr (2012) 2.67

Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev (2009) 2.65

Weight of nations: a socioeconomic analysis of women in low- to middle-income countries. Am J Clin Nutr (2010) 2.33

Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study. BMJ (2008) 2.33

Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol (2010) 2.25

Changes in weight, waist circumference and compensatory responses with different doses of exercise among sedentary, overweight postmenopausal women. PLoS One (2009) 2.08

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J (2013) 2.02

Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg (2013) 1.91

Atomic structure of the cross-beta spine of islet amyloid polypeptide (amylin). Protein Sci (2008) 1.89

Metabolic complications of androgen deprivation therapy for prostate cancer. J Urol (2009) 1.86

Inhibition of the TRPC5 ion channel protects the kidney filter. J Clin Invest (2013) 1.76

Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health (2009) 1.68

Childhood maltreatment and obesity: systematic review and meta-analysis. Mol Psychiatry (2013) 1.64

Lipotoxicity in the heart. Biochim Biophys Acta (2009) 1.60

Prevalence of hypertension in china: a cross-sectional study. PLoS One (2013) 1.60

Birth weight and long-term overweight risk: systematic review and a meta-analysis including 643,902 persons from 66 studies and 26 countries globally. PLoS One (2012) 1.58

The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance. Endocr Rev (2009) 1.57

Biomechanical factors in osteoarthritis. Best Pract Res Clin Rheumatol (2011) 1.56

Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27). Diabetologia (2012) 1.51

Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis. J Clin Microbiol (2008) 1.50

Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity. Sci Rep (2014) 1.48

Obesity and diabetes in vulnerable populations: reflection on proximal and distal causes. Ann Fam Med (2007) 1.48

Prevalences of overweight, obesity, hyperglycaemia, hypertension and dyslipidaemia in the Gulf: systematic review. JRSM Short Rep (2011) 1.48

Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process. Protein Sci (2009) 1.46

Human islet amyloid polypeptide monomers form ordered beta-hairpins: a possible direct amyloidogenic precursor. J Am Chem Soc (2009) 1.46

Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes (2014) 1.44

The future of endocannabinoid-oriented clinical research after CB1 antagonists. Psychopharmacology (Berl) (2009) 1.42

A systems biology approach identifies inflammatory abnormalities between mouse strains prior to development of metabolic disease. Diabetes (2010) 1.41

Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care (2009) 1.41

Urban-rural differences in BMI in low- and middle-income countries: the role of socioeconomic status. Am J Clin Nutr (2013) 1.39

The H3K27 demethylase, Utx, regulates adipogenesis in a differentiation stage-dependent manner. PLoS One (2017) 1.39

The effect of bariatric surgeries on nonalcoholic fatty liver disease. Saudi J Gastroenterol (2014) 1.39

Therapeutic Potential of Moringa oleifera Leaves in Chronic Hyperglycemia and Dyslipidemia: A Review. Front Pharmacol (2012) 1.36

FTO gene polymorphisms and obesity risk: a meta-analysis. BMC Med (2011) 1.34

Measuring markers of liver function using a micropatterned paper device designed for blood from a fingerstick. Anal Chem (2012) 1.33

Diabetes in sub-saharan Africa: kenya, mali, mozambique, Nigeria, South Africa and zambia. Int J Diabetes Dev Ctries (2008) 1.33

Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: an international multicenter cohort study. Crit Care (2013) 1.31

Adaptive immunity and adipose tissue biology. Trends Immunol (2010) 1.29

Long-term fine particulate matter exposure and mortality from diabetes in Canada. Diabetes Care (2013) 1.29

Support for agriculture during economic transformation: impacts on poverty and undernutrition. Proc Natl Acad Sci U S A (2010) 1.29

Fighting fat with fat: the expanding field of adipose stem cells. Cell Stem Cell (2009) 1.25

The developmental origins of adipose tissue. Development (2013) 1.24

Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. Cardiovasc Diabetol (2009) 1.22

Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms. Anesthesiology (2008) 1.19

Non-communicable diseases and global health governance: enhancing global processes to improve health development. Global Health (2007) 1.19

Brown adipose tissue--a new role in humans? Nat Rev Endocrinol (2010) 1.18

Independent stem cell lineages regulate adipose organogenesis and adipose homeostasis. Cell Rep (2014) 1.18

Modifiable socio-behavioural factors associated with overweight and hypertension among persons aged 35 to 60 years in eastern Uganda. PLoS One (2012) 1.17

Temporal trends and correlates of physical activity, sedentary behaviour, and physical fitness among school-aged children in Sub-Saharan Africa: a systematic review. Int J Environ Res Public Health (2014) 1.17

Prospective study of dietary energy density and weight gain in women. Am J Clin Nutr (2008) 1.15

Prevalence of metabolic syndrome among Hispanics/Latinos of diverse background: the Hispanic Community Health Study/Study of Latinos. Diabetes Care (2014) 1.12

Trends in overweight and obesity in Lebanon: evidence from two national cross-sectional surveys (1997 and 2009). BMC Public Health (2012) 1.11

Obesity epidemiology. Clin Colon Rectal Surg (2011) 1.11

Framing international trade and chronic disease. Global Health (2011) 1.11

Inadequate diabetic care: global figures cry for preventive measures and personalized treatment. EPMA J (2010) 1.10

Positional cloning of "Lisch-Like", a candidate modifier of susceptibility to type 2 diabetes in mice. PLoS Genet (2008) 1.10

The co-management of tuberculosis and diabetes: challenges and opportunities in the developing world. PLoS Med (2012) 1.09

Predicting physical activity energy expenditure using accelerometry in adults from sub-Sahara Africa. Obesity (Silver Spring) (2009) 1.08

The Nutrition and Enjoyable Activity for Teen Girls (NEAT girls) randomized controlled trial for adolescent girls from disadvantaged secondary schools: rationale, study protocol, and baseline results. BMC Public Health (2010) 1.08

Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone. J Clin Endocrinol Metab (2010) 1.05

Long-term impact of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight and glycemic control in Japanese type 2 diabetes: an observational study. Diabetol Metab Syndr (2014) 1.05

Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology (2011) 1.05

Dietary pattern and its association with the prevalence of obesity and related cardiometabolic risk factors among Chinese children. PLoS One (2012) 1.04

Sustained self-regulation of energy intake. Loss of weight in overweight subjects. Maintenance of weight in normal-weight subjects. Nutr Metab (Lond) (2010) 1.04

Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy. Stem Cells (2009) 1.04

Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes. Cardiovasc Diabetol (2011) 1.04

Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity. Cardiovasc Diabetol (2012) 1.03

Divergent fifteen-year trends in traditional and cardiometabolic risk factors of cardiovascular diseases in the Seychelles. Cardiovasc Diabetol (2009) 1.03

Homocysteine serum levels in diabetic patients with non proliferative, proliferative and without retinopathy. Biomed Res Int (2014) 1.03

Type 2 diabetes, mitochondrial biology and the heart. J Mol Cell Cardiol (2009) 1.03

The impact of female obesity on the outcome of fertility treatment. J Hum Reprod Sci (2010) 1.03

New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a Middle East population. Cardiovasc Diabetol (2010) 1.03

The renin-angiotensin-aldosterone system and glucose homeostasis. Trends Pharmacol Sci (2011) 1.03

Differentiation of Human Adipose-Derived Stem Cells into "Brite" (Brown-in-White) Adipocytes. Front Endocrinol (Lausanne) (2011) 1.03

Insulin resistance is associated with significant clinical atherosclerosis in nondiabetic patients with acute myocardial infarction. Arterioscler Thromb Vasc Biol (2013) 1.02

Naringin improves diet-induced cardiovascular dysfunction and obesity in high carbohydrate, high fat diet-fed rats. Nutrients (2013) 1.01

Strategy to combat obesity and to promote physical activity in Arab countries. Diabetes Metab Syndr Obes (2011) 1.01

Bariatric surgery and diabetes remission: sleeve gastrectomy or mini-gastric bypass? World J Gastroenterol (2013) 1.00

Underestimation of weight and its associated factors among overweight and obese adults in Pakistan: a cross sectional study. BMC Public Health (2011) 1.00

Heritability of insulin sensitivity and lipid profile depend on BMI: evidence for gene-obesity interaction. Diabetologia (2009) 1.00

The usefulness of circulating adipokine levels for the assessment of obesity-related health problems. Int J Med Sci (2008) 0.99

The role of gut microbiota on insulin resistance. Nutrients (2013) 0.99

Uncoupling protein 2 gene polymorphisms are associated with obesity. Cardiovasc Diabetol (2012) 0.98

Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study. J Clin Endocrinol Metab (2012) 0.97

The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome. Curr Hypertens Rep (2012) 0.97

Inflammation and cellular stress: a mechanistic link between immune-mediated and metabolically driven pathologies. Eur J Nutr (2011) 0.97

Recent advances in the molecular genetics of type 2 diabetes mellitus. World J Diabetes (2014) 0.97

Relationship between adiposity and admixture in African-American and Hispanic-American women. Int J Obes (Lond) (2011) 0.97

Adiponectin and energy homeostasis. Rev Endocr Metab Disord (2014) 0.96

Articles by these authors

The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int (2010) 9.25

Podocyte number in normotensive type 1 diabetic patients with albuminuria. Diabetes (2002) 2.12

CKD and poverty: a growing global challenge. Am J Kidney Dis (2009) 1.62

OPPORTUNITY™: a large-scale randomized clinical trial of growth hormone in hemodialysis patients. Nephrol Dial Transplant (2011) 1.44

A study of the natural history of diabetic kidney disease (DKD). Nephrol Dial Transplant (2011) 1.22

Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration. Kidney Int Suppl (2005) 1.16

Microalbuminuria: marker or maker of cardiovascular disease. Nephron Exp Nephrol (2011) 1.13

Endothelin B receptor blockade accelerates disease progression in a murine model of autosomal dominant polycystic kidney disease. J Am Soc Nephrol (2007) 1.10

Socioeconomic status and chronic kidney disease at presentation to a renal service in the United Kingdom. Clin J Am Soc Nephrol (2008) 1.09

Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study. Nephron Clin Pract (2009) 1.03

Early histological changes in the kidney of people with morbid obesity. Nephrol Dial Transplant (2009) 1.03

Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk. J Am Soc Nephrol (2007) 1.00

Chronic kidney disease in older people: physiology, pathology or both? Nephron Clin Pract (2010) 0.96

Impact of weight change on albuminuria in the general population. Nephrol Dial Transplant (2007) 0.96

Establishment of a European Network for Urine and Kidney Proteomics. J Proteomics (2008) 0.89

A population-based screening for microalbuminuria among relatives of CKD patients: the Kidney Evaluation and Awareness Program in Sheffield (KEAPS). Am J Kidney Dis (2008) 0.89

Modulation of tissue transglutaminase in tubular epithelial cells alters extracellular matrix levels: a potential mechanism of tissue scarring. Matrix Biol (2008) 0.85

Chapter 13 The linkage of incident renal replacement therapy patients in England (2002-2006) to hospital episodes and national mortality data: improved demography and hospitalisation data in patients undergoing renal replacement therapy. Nephron Clin Pract (2012) 0.83

Egypt Information, Prevention, and Treatment of Chronic Kidney Disease (EGIPT-CKD) programme: prevalence and risk factors for microalbuminuria among the relatives of patients with CKD in Egypt. Saudi J Kidney Dis Transpl (2011) 0.83

Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for. Proteomics Clin Appl (2011) 0.82

Cosegregation of focal segmental glomerulosclerosis in a family with familial partial lipodystrophy due to a mutation in LMNA. Nephron Clin Pract (2013) 0.82

Variation in centre-specific survival in patients starting renal replacement therapy in England is explained by enhanced comorbidity information from hospitalization data. Nephrol Dial Transplant (2013) 0.81

Potential role of growth factors with particular focus on growth hormone and insulin-like growth factor-1 in the management of chronic kidney disease. Semin Nephrol (2009) 0.81

Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome? Nephrol Dial Transplant (2012) 0.81

The Kidney Evaluation and Awareness Program in Sheffield (KEAPS): a community-based screening for microalbuminuria in a British population. Nephron Clin Pract (2010) 0.79

OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients. Clin J Am Soc Nephrol (2008) 0.78

Proteinuria thresholds are irrational: a call for proteinuria indexing. Nephron Clin Pract (2010) 0.78

The epidemic challenge of chronic kidney disease in older patients. Postgrad Med (2008) 0.77

Cardiovascular effects of growth hormone in adult hemodialysis patients: results from a randomized controlled trial. Nephron Clin Pract (2010) 0.76

Chronic kidney disease in Taiwan. Lancet (2008) 0.75

Twins and CKD: confounding nature's experiments! Nephrol Dial Transplant (2011) 0.75

Urinary albumin to protein ratio: more of the same or making a difference? Nephrol Dial Transplant (2012) 0.75

Screening strategies for CKD. Nephrol Dial Transplant (2010) 0.75

Introducing 'nephron clinical guidelines'. Nephron Clin Pract (2008) 0.75

New evidence of cardiac dysfunction associated with renal impairment. Int J Cardiol (2011) 0.75

Renal remodelling: complex interactions between renal and extra-renal cells. Pediatr Nephrol (2006) 0.75

Stopping renin-angiotensin system inhibitors in chronic kidney disease: predictors of response. Nephron Clin Pract (2011) 0.75